Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) Net Margin (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Net Margin for 10 consecutive years, with 16.4% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 1411.0% to 16.4% in Q4 2025 year-over-year; TTM through Dec 2025 was 16.78%, a 170.0% increase, with the full-year FY2025 number at 16.78%, up 170.0% from a year prior.
  • Net Margin was 16.4% for Q4 2025 at Orthopediatrics, up from 19.22% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 53.04% in Q3 2022 to a low of 48.36% in Q1 2021.
  • A 5-year average of 14.13% and a median of 15.46% in 2025 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: surged 7434bps in 2021, then plummeted -6453bps in 2023.
  • Orthopediatrics' Net Margin stood at 0.29% in 2021, then plummeted by -8826bps to 25.32% in 2022, then rose by 30bps to 17.79% in 2023, then plummeted by -72bps to 30.51% in 2024, then skyrocketed by 46bps to 16.4% in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Net Margin are 16.4% (Q4 2025), 19.22% (Q3 2025), and 11.65% (Q2 2025).